Technical Articles

Nectin-4
Nectin-4：肿瘤治疗的新兴靶点与应用前景
Nectin-4: Emerging Targets and Application Prospects for Tumor Therapy
发布时间 2025-07-24
ADC couples highly targeted monoclonal antibodies with cytotoxic chemotherapy drugs through specific biochemical linkers to achieve "targeted chemotherapy", accurately releasing cytotoxic drugs at the tumor site, exerting potent anti-tumor effects while reducing damage to normal tissues
View details
  • Cancer
  • Nectin-4
  • tumor
Total 1
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.